Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SEC vs Boock et al (Feb 1 Update)
Pacer update
01 Feb 10 1:09-cv-08261-DLC Securities and Exchange Commission v. Boock et al
01/29/2010 19 ORDER: For the reasons stated on the record at the conference on January 29, 2010, defendant Jason C. Wong's October 26 motion to dismiss the complaint is denied. (Signed by Judge Denise L. Cote on 1/29/2010) (jfe) (Entered: 02/01/2010)
Doc 19 PDF file
http://www.viewer.zoho.com/docs/lP6ce/
01/27/2010 18 MOTION TO QUASH SERVICE AND MOTION TO DISMISS THE COMPLAINT. Document filed by Nicolette D. Loisel.(mro) (Entered: 01/29/2010)
01/14/2010 17 AFFIDAVIT OF SERVICE. Nicolette D. Loisel served on 10/12/2009, answer due 11/2/2009. Service was accepted by Leticia (security officer). Document filed by Securities and Exchange Commission. (Kisslinger, Paul) (Entered: 01/14/2010)
Defendant Irwin Boock
Defendant Stanton B.J. Defreitas
Defendant Nicolette D. Loisel
Defendant Roger L. Shoss
Defendant Jason C. Wong
Relief Defendant Birte Boock
Relief Defendant 1621566 Ontario, Inc.
Source: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46130725
sine die...means...no date.
That would seem to leave us hanging till H freeze over.
I have no idea. OSC didn't provide an explanation. The SEC filed a civil complaint against the crooks in October 2009 (See post at top). It's possible that the SEC is now lead on the prosecution and OSC will provide support.
If you have access to PACER, you can follow the SEC case against the crooks.
with that info will it be possible that it will start to trade again ? the second to last line said that it is in the public interest to make this order. last line states the hearing on the merits is adjourned sine die... what's that supposed to mean? i'm no lawyer. i'm going to email the company again and see if i get a response. thanks for your input!!
OSC Adjourns Hearing Until Further Notice
January 29, 2010 OSC Order
"WHEREAS on October 16, 2008, the Ontario Securities Commission (the “Commission”) issued a Notice of Hearing pursuant to sections 127 and 127.1 of the Securities Act, R.S.O. 1990, c. S.5, as amended (the “Act”) in connection with a Statement of Allegations issued by and Staff of the Commission (“Staff”);
AND WHEREAS on December 10, 2009, the Commission ordered that the hearing on the merits in this matter shall commence on February 1, 2010 at 10:00 a.m.;
AND WHEREAS on January 8, 2010, the Commission heard a motion pursuant to an application by Staff (the “Motion”);
AND WHEREAS the Commission reserved its decision on the Motion and the decision remains pending;
AND WHEREAS the adjournment of this matter pending release of the Commission’s decision on the Motion is not opposed;
AND WHEREAS the Commission is of the opinion that it is in the public interest to make this Order;
IT IS ORDERED THAT the hearing on the merits is adjourned sine die.
DATED at Toronto this 29th day of January, 2010."
OFFICE OF THE SECRETARY
JOHN P. STEVENSON
SECRETARY
For media inquiries: Wendy Dey
Director, Communications & Public Affairs
416-593-8120
Theresa Ebden
Senior Communications Specialist
416-593-8307
Robert Merrick
Senior Communications Specialist
416-593-2315
For Investor Inquiries: OSC Contact Centre
416-593-8314
1-877-785-1555 (Toll Free)
Source:
http://www.osc.gov.on.ca/en/Proceedings_rad_20100129_boocki.htm
http://www.osc.gov.on.ca/documents/en/Proceedings-RAD/rad_20100129_boocki.pdf
- Adjournment sine die (from the Latin "without day") means "without assigning a day for a further hearing".
January 29, 2010 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20100129_boocki.htm
December 11, 2009 Notice
TORONTO – The Commission issued an Order in the above named matter which provides that the dates for the hearing of this matter on the merits shall commence on February 1, 2010 at 10:00 a.m. and shall continue for four weeks excluding the dates of February 2, 15 and 16 or such other dates as may be determined by the parties and the Office of the Secretary.
December 11, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091211_boocki.htm
December 10, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_rad_20091210_boocki.htm
November 30, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091130_boocki.htm
November 30, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_rad_20091130_boocki.htm
October 22, 2009 Settlement Agreement
http://www.osc.gov.on.ca/documents/en/Proceedings-SET/Proceedings_set_20091021_booki.pdf
October 21, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_enr_20091016_boocki.htm
October 22, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091022_boocki.htm
October 19, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091019_boocki.htm
October 19, 2009 Notice of Hearing
http://www.osc.gov.on.ca/en/Proceedings_noh_20091019_boocki.htm
October 15, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_rad_20091015_boocki.htm
October 16, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091016_boocki.htm
I called Scottrade and took my loss last year on this POS, had no problem disposing of it, did have to pay a fee, wasn't much though, and got me the stock loss.......
Just request your broker to dispose them, they might charge you a small fee though, or consult with your tax-advisor on taking losses on worthless equity.
To anyone who has the answers:
1. How many years you have to write off the loss in a stock like PMCL (I bought it back in 2007)?
2. How do you sell a stock like PMCL to take loss write of when it is not tradable and has 0.00 value?
3)Or the only viable option is to "take the lump" and lose just the money?
Your thoughts would be much appreciated...TIA
Sell them? How? There is no market for them.
Most people are still holding until the outcome of the OSC hearing this year. If you sell, you can use your loss to offset any capital gains in 2010.
so then if I am understanding...i am to sell my POS shares for a loss then. :)
The stock no longer trades. De-listed by the SEC and OSC.
See OSC links for case against the alleged conspirators who hijacked the stock symbol, released false press releases, pumped the message boards, and sold shares for profit.
hope this turns around...we shall see.
now it has become just a dollar[multiplied by many] and a dream. lets go pmcl....... wow am i on drugs,,, well HAPPY NEW YEAR!!! best to all involved!!!
OSC Releases - Feb 1, 2010 Hearing
December 11, 2009 Notice
TORONTO – The Commission issued an Order in the above named matter which provides that the dates for the hearing of this matter on the merits shall commence on February 1, 2010 at 10:00 a.m. and shall continue for four weeks excluding the dates of February 2, 15 and 16 or such other dates as may be determined by the parties and the Office of the Secretary.
December 11, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091211_boocki.htm
December 10, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_rad_20091210_boocki.htm
November 30, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091130_boocki.htm
November 30, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_rad_20091130_boocki.htm
October 22, 2009 Settlement Agreement
http://www.osc.gov.on.ca/documents/en/Proceedings-SET/Proceedings_set_20091021_booki.pdf
October 21, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_enr_20091016_boocki.htm
October 22, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091022_boocki.htm
October 19, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091019_boocki.htm
October 19, 2009 Notice of Hearing
http://www.osc.gov.on.ca/en/Proceedings_noh_20091019_boocki.htm
October 15, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_rad_20091015_boocki.htm
October 16, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091016_boocki.htm
by then it will be just about 3 yrs that i've been holding... happy holiday's!!
The OSC posted last evening.
Mext hearing is scheduled for Feb.1,2010 and will run for approximately four weeks.
Same old nonsense. It appears the only one getting anything done at the OSC is their scheduler as usual.
next week will bring the same thing every week has brought since we all got scammed......NOTHING,,,,I am glad I sold this and took the loss a while back, nothing is going to happen with this just like nothing happens with all these scams!
called the osc again today at 3:15pm est. nothing yet to talk about, nothing yet posted on there website, w'ell see what next week brings. best to all!!!
went on the osc website just a short while ago and nothing posted yet of the out come. called the toll free #, spoke with John, he told me that the hearing went off as scheduled, to look for info after 5pm or possibly tommorrow. lets see...
I told you guys from the start it is a scam and can just write off the tax-loss. ZERO HOPE of any recovery.
after waiting almost 3 yrs sarcasm is duly deserved. best to you!!!
Next Hearing for this mess is scheduled at the OSC on December 10 at 11:30 AM.
Maybe they ( OSC ) will get it taken care of by 2025.....sorry for the touch of sarcasm.
Doesn't contain any compensation to the shareholders.
December 1 another hearing.
Link to latest OSC releases
Nothing new from OSC since the NutriOne settlement. I don't see any future hearing dates for PMCL and the other shells created by Irwin Boock et al ???
October 22, 2009 Settlement Agreement
http://www.osc.gov.on.ca/documents/en/Proceedings-SET/Proceedings_set_20091021_booki.pdf
October 21, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_enr_20091016_boocki.htm
October 22, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091022_boocki.htm
October 19, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091019_boocki.htm
October 19, 2009 Notice of Hearing
http://www.osc.gov.on.ca/en/Proceedings_noh_20091019_boocki.htm
October 15, 2009 Order
http://www.osc.gov.on.ca/en/Proceedings_rad_20091015_boocki.htm
October 16, 2009 Notice
http://www.osc.gov.on.ca/en/Proceedings_enr_20091016_boocki.htm
Now that the sec is going after the "gang" we should be just like the cyberkey holders and this court order for ckys should be in our future, read it!!
IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA
UNITED STATES OF AMERICA :
:
v. : CRIMINAL NO. 07-375-1
:
JAMES PLANT :
ORDER
AND NOW, this 11th day of March, 2009, upon consideration of the Government
’s motion to delay final order of restitution, it appearing that:
a.
defendant’s sentencing hearing is scheduled for March 23, 2009;
b.
a comprehensive calculation of the victims’ losses will not be available by the date of sentencing, since the Government continues to receive responses to the victim notification letter and questionnaire it mailed to approximately 3,228 potential victims of the CyberKey fraud to which defendant entered a plea of guilty;
c.
delaying the final determination of the restitution calculation would provide the victims with the maximum amount of time to respond to the victim notification letter and questionnaire, thereby making them eligible for restitution from the Government; and
d. there is no prejudice to defendant in granting this request. It is therefore ORDERED that:
1. The Government’s unopposed motion (paper no. 92) is GRANTED.
2.
Counsel for the Government shall provide the court, defense counsel, and the U.S. Probation Office with a detailed analysis of the final restitution amount, listing each victim and the amount of restitution owed on or before MAY 22, 2009.
3.
A hearing will be held on JUNE 22, 2009 at 10:00 A.M. in Courtroom 10-A, at which a final determination of defendant’s restitution obligation will be made.
Well, there is little point to a board, but I check in once in a while to see if there is any news on the action against the bad guys.
hello to all, this board seems to be about as dead as this stock
Like I said many years ago, you won't see any disgorgement for bagholders. Expect a 100% loss for tax write-off. Pumpers gave you guys the last hope and said disgorgement lol.
Latest News Headlines for Pharm Control Ltd
Notice from the Office of the Secretary - In the matter of the Securities Act R.S.O. 1990, c. S.5, as amended - And - In the matter of Irwin Boock, Stanton Defreitas, Jason Wong, Saudia Allie, Alena Dubinsky, Alex Khodjiaints Select American Transfer Co., Leasesmart, Inc., Advanced Growing Systems, Inc., International Energy Ltd., Nutrione Corporation, Pocketop Corporation, Asia Telecom Ltd., Pharm Control Ltd., Cambridge Resources Corporation, Compushare Transfer Corporation, Federated Purchaser, Inc., TCC Industries, Inc., First National Entertainment Corporation, WGI Holdings, Inc. and Enerbrite Technologies Group
Thursday 10/22/2009 6:27 PM ET - CNW Group
Following a hearing held on October 21, 2009, the Commission issued an Order approving the Settlement Agreement reached between Staff of the Commission and NutriOne Corporation.
A copy of the Order dated October 21, 2009 and Settlement Agreement dated October 21, 2009 are available at www.osc.gov.on.ca
Good job Philly. Thanks for the update. The issue will be resolved, maybe not the way we would all want, but at least a resolution is coming to finally end this mess. On our own turf no less!
SEC v Boock, DeFreitas, Loisel, Shoss & Wong
Complaint: http://www.sec.gov/litigation/complaints/2009/comp21243.pdf
SEC Litigation Release No. 21243 / October 8, 2009
SEC v. Irwin Boock, Stanton B. J. DeFreitas, Nicolette D. Loisel, Roger L. Shoss, and Jason C. Wong, Birte Boock, and 1621566 Ontario, Inc., Civil Action No. 09 CV 8261 (S.D.N.Y) (DLC)
SEC Charges Five With Dozens of Fraudulent Corporate Hijackings and Unregistered Offerings of Securities and Names Two Relief Defendants
On September 29, 2009, the United States Securities and Exchange Commission filed a civil injunctive action against Irwin Boock, Stanton B. J. DeFreitas, and Jason C. Wong, all of Ontario, Canada, and two Houston-based attorneys, Roger L. Shoss and Nicolette D. Loisel, charging them with having violated the antifraud and registration provisions of the federal securities laws by effecting dozens of corporate hijackings and making unregistered offerings and sales of shares. The complaint also names as relief defendants Boock's wife, Birte Boock, and a company of which she allegedly was the sole officer and director during the relevant period, 1621566 Ontario, Inc.
The Commission's complaint alleges that the hijackings were effected by identifying inactive or defunct publicly-traded corporations which were no longer operating and either illicitly revivifying the corporations by falsely representing that the defendants were duly authorized officers, directors, or agents of the corporations or by incorporating new corporations using the names of the void corporation. Once an inactive corporation was revivified or a new corporation formed, the complaint alleges that the defendants immediately effected a name change in the corporation and requested from third parties responsible for assigning unique identifiers to each class of securities issued by a publicly-traded corporation a new identifying number known as a CUSIP number and ticker symbol. According to the complaint, these identifiers were obtained by falsely representing that the companies seeking new CUSIPs and ticker symbols were the same companies to which CUSIP numbers and ticker symbols had previously been issued and that the name changes triggering the need for new identifiers were duly authorized corporate actions.
The complaint alleges that Boock recruited Shoss and Loisel in late 2003 to handle the paperwork required to effect hijackings, including submitting false documentation to Secretaries of State, the Standard & Poor's CUSIP Service Bureau, transfer agents, and Nasdaq Corporate Data Operations which, during the relevant period, processed requests for ticker symbols. The complaint further alleges that from November 2003 through March 2006, Boock, Shoss, and Loisel effected at least 22 corporate hijackings. From November 2003 through June 2007, Boock, Wong, and DeFreitas allegedly effected at least another 21 corporate hijackings.
With respect to at least 19 of those corporations hijacked with Shoss and Loisel's involvement, the complaint alleges that Shoss and Loisel were tasked to provide 28 opinion letters falsely representing that offerings of approximately 223 million shares were exempt from the registration requirements of the federal securities laws. The complaint alleges that Boock dispensed with the need for obtaining legal opinion letters concerning the issuance of shares by the 21 hijacking corporations involving Wong and DeFreitas by incorporating his own transfer agency, Select American Transfer Company, which Wong and DeFreitas operated. With respect to these 21 companies, the complaint further alleges that the three men effected the unregistered offerings of up to seven billion shares.
The complaint also alleges that DeFreitas effected unregistered sales in the securities of at least 30 of the hijacked or hijacking entities, generating at least $2.2 million in illicit proceeds. Boock allegedly effected unregistered sales of securities in at least five of the hijacked or hijacking entities, generating at least $267,625 in illicit proceeds. Wong allegedly effected unregistered sales of securities in at least 11 of the hijacked or hijacking entities.
The complaint alleges that each of the defendant received illicit proceeds in the form of remuneration for services, proceeds from the sale of the shell companies to buyers, and/or from the sale of shares in purported private placements or into the secondary market.
Based on the foregoing, the Commission's complaint alleges that the five defendants violated Sections 5(a) and (c) and 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The complaint further alleges that Boock violated a penny stock bar instituted against him in 2002 in a settled administrative proceeding (see In the Matter of Birte Boock and Irwin Boock, Admin. Proc. File No. 3-10960 (Ex. Act Rel. No. 46952)), thereby violating Exchange Act Section 15(b)(6)(B)(i). With respect to each of the five defendants, the Commission is seeking a permanent injunction, a judicial penny stock bar, disgorgement with prejudgment interest, and civil penalties. The Commission is also seeking officer and director bars against Boock and Wong.
On September 23, 2009, the Commission issued an order suspending trading in the securities of 17 of the above-mentioned issuers pursuant to Exchange Act Section 12(k). See Ex. Act Rel. No. 60707. The Commission previously instituted a trading suspension on March 13, 2008 with respect 26 issuers, 11 of which are identified in the Commission's complaint as having been newly incorporated by Boock, Shoss and Loisel and used in the scheme. See Release No. 57486 (March 13, 2008).
Any person with information relating to this matter should contact John Polise, Assistant Director, Division of Enforcement of the Securities and Exchange Commission by calling 202-551-4600 or by sending an email to ENF-17suspensions@sec.gov.
The Commission acknowledges the assistance and cooperation of the Royal Canadian Mounted Police, the Ontario Securities Commission, the U.S. Attorney's Office for the Middle District of Florida in Tampa, the U.S. Attorney's Office for the District of New Jersey in Newark, the Newark and Tampa Field Offices of the U.S. Secret Service, U.S. Immigration and Customs Enforcement (ICE), and the Financial Industry Regulatory Authority (FINRA).
http://www.sec.gov/litigation/litreleases/2009/lr21243.htm
Lesson learned and take tax loss at end of year.
The stock symbol was hijacked by criminals. There is no company behind the stock symbol. Nothing we can do at this point except wait and see if the SEC is able to set up a disgorgement fund by collecting ill-gotten gains from the crooks.
what does this mean to shareholders?
SEC Litigation Release No. 21243 / October 8, 2009
SEC v. Irwin Boock, Stanton B. J. DeFreitas, Nicolette D. Loisel, Roger L. Shoss, and Jason C. Wong, Birte Boock, and 1621566 Ontario, Inc., Civil Action No. 09 CV 8261 (S.D.N.Y) (DLC)
SEC Charges Five With Dozens of Fraudulent Corporate Hijackings and Unregistered Offerings of Securities and Names Two Relief Defendants
On September 29, 2009, the United States Securities and Exchange Commission filed a civil injunctive action against Irwin Boock, Stanton B. J. DeFreitas, and Jason C. Wong, all of Ontario, Canada, and two Houston-based attorneys, Roger L. Shoss and Nicolette D. Loisel, charging them with having violated the antifraud and registration provisions of the federal securities laws by effecting dozens of corporate hijackings and making unregistered offerings and sales of shares. The complaint also names as relief defendants Boock's wife, Birte Boock, and a company of which she allegedly was the sole officer and director during the relevant period, 1621566 Ontario, Inc.
The Commission's complaint alleges that the hijackings were effected by identifying inactive or defunct publicly-traded corporations which were no longer operating and either illicitly revivifying the corporations by falsely representing that the defendants were duly authorized officers, directors, or agents of the corporations or by incorporating new corporations using the names of the void corporation. Once an inactive corporation was revivified or a new corporation formed, the complaint alleges that the defendants immediately effected a name change in the corporation and requested from third parties responsible for assigning unique identifiers to each class of securities issued by a publicly-traded corporation a new identifying number known as a CUSIP number and ticker symbol. According to the complaint, these identifiers were obtained by falsely representing that the companies seeking new CUSIPs and ticker symbols were the same companies to which CUSIP numbers and ticker symbols had previously been issued and that the name changes triggering the need for new identifiers were duly authorized corporate actions.
The complaint alleges that Boock recruited Shoss and Loisel in late 2003 to handle the paperwork required to effect hijackings, including submitting false documentation to Secretaries of State, the Standard & Poor's CUSIP Service Bureau, transfer agents, and Nasdaq Corporate Data Operations which, during the relevant period, processed requests for ticker symbols. The complaint further alleges that from November 2003 through March 2006, Boock, Shoss, and Loisel effected at least 22 corporate hijackings. From November 2003 through June 2007, Boock, Wong, and DeFreitas allegedly effected at least another 21 corporate hijackings.
With respect to at least 19 of those corporations hijacked with Shoss and Loisel's involvement, the complaint alleges that Shoss and Loisel were tasked to provide 28 opinion letters falsely representing that offerings of approximately 223 million shares were exempt from the registration requirements of the federal securities laws. The complaint alleges that Boock dispensed with the need for obtaining legal opinion letters concerning the issuance of shares by the 21 hijacking corporations involving Wong and DeFreitas by incorporating his own transfer agency, Select American Transfer Company, which Wong and DeFreitas operated. With respect to these 21 companies, the complaint further alleges that the three men effected the unregistered offerings of up to seven billion shares.
The complaint also alleges that DeFreitas effected unregistered sales in the securities of at least 30 of the hijacked or hijacking entities, generating at least $2.2 million in illicit proceeds. Boock allegedly effected unregistered sales of securities in at least five of the hijacked or hijacking entities, generating at least $267,625 in illicit proceeds. Wong allegedly effected unregistered sales of securities in at least 11 of the hijacked or hijacking entities.
The complaint alleges that each of the defendant received illicit proceeds in the form of remuneration for services, proceeds from the sale of the shell companies to buyers, and/or from the sale of shares in purported private placements or into the secondary market.
Based on the foregoing, the Commission's complaint alleges that the five defendants violated Sections 5(a) and (c) and 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The complaint further alleges that Boock violated a penny stock bar instituted against him in 2002 in a settled administrative proceeding (see In the Matter of Birte Boock and Irwin Boock, Admin. Proc. File No. 3-10960 (Ex. Act Rel. No. 46952)), thereby violating Exchange Act Section 15(b)(6)(B)(i). With respect to each of the five defendants, the Commission is seeking a permanent injunction, a judicial penny stock bar, disgorgement with prejudgment interest, and civil penalties. The Commission is also seeking officer and director bars against Boock and Wong.
On September 23, 2009, the Commission issued an order suspending trading in the securities of 17 of the above-mentioned issuers pursuant to Exchange Act Section 12(k). See Ex. Act Rel. No. 60707. The Commission previously instituted a trading suspension on March 13, 2008 with respect 26 issuers, 11 of which are identified in the Commission's complaint as having been newly incorporated by Boock, Shoss and Loisel and used in the scheme. See Release No. 57486 (March 13, 2008).
Any person with information relating to this matter should contact John Polise, Assistant Director, Division of Enforcement of the Securities and Exchange Commission by calling 202-551-4600 or by sending an email to ENF-17suspensions@sec.gov.
The Commission acknowledges the assistance and cooperation of the Royal Canadian Mounted Police, the Ontario Securities Commission, the U.S. Attorney's Office for the Middle District of Florida in Tampa, the U.S. Attorney's Office for the District of New Jersey in Newark, the Newark and Tampa Field Offices of the U.S. Secret Service, U.S. Immigration and Customs Enforcement (ICE), and the Financial Industry Regulatory Authority (FINRA).
http://www.sec.gov/litigation/litreleases/2009/lr21243.htm
SEC Complaint: http://viewer.zoho.com/docs/x8Ocy
Thanks! Good find.
The SEC will be posting the announcement soon:
http://www.sec.gov/litigation/litreleases.shtml
The crooks will go to trial in about 2 years if they don't settle.
We'll see what happens with the OSC complaint on October 25th.
We are on page #24
http://viewer.zoho.com/docs/x8Ocy
I told you guys that years ago. I told you guys that when it was still trading in pennies. I GOT BASHED BACK THEN!!
Screw them canadian crooks. Got no faith in OSC or that backwash dump to the north. All they do is keep postponing the trials to reward the criminals. There is no hope for individual investors so why should Oct19 be any different..
so after 2 1/2 yrs we still have some hope? GLTA!!!
October 19, 2009 - Next OSC Hearing
The Commission issued an Order which provides that the hearing of this matter on the merits shall be held on Monday, October 19, 2009 through to Friday, November 13, 2009, excluding Wednesday, November 11, 2009, commencing each day at 10:00 a.m. at the offices of the Commission on the 17th floor, 20 Queen Street West in Toronto.
http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20090428_boocki.jsp
All OSC notices for Pharm Control LTD (scroll down)
http://www.osc.gov.on.ca/Enforcement/Proceedings/AlphaListing/ep_p_index.jsp
hhhheeeellllloooooooo..... aaaaannnnyyyybbbbooooodddddyyyyyyy......oooouuuuutttttt......tttthhhheeeeerrrrreeeee??????
Thanks Philly for keeping the board alive. We wait....heck, what's another couple of months of waiting after a couple of years have passed already. I'm still curious about Freitas and crew supposedly having sold a few of the shells that they were playing if they didn't own them in the first place as well as the purpose of PMCL's attorney that kept showing up at most of the hearings.
NOTHING NEW
Here's the latest news if you missed it.
IT IS ORDERED THAT:
1. the Temporary Order is varied such that DeFreitas may direct TD Waterhouse and TD Bank to sell securities held in his accounts with them to liquidate the accounts; and,
2. the Temporary Order, as varied by this Order, is otherwise extended until the conclusion of this proceeding or until further order of the Commission.
July 9, 2009
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090709_boocki.jsp
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090709_boocki.pdf
July 14, 2009
http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20090714_boocki.jsp
right, wrong, or indifferent, a MM's job is to create a market even if one does not exist. whether they are trading amongst themselves or someone actually bought 84,000 @ 0.001 it only amounts to $84. like some here, i have been holding my position since 04/2007. whatever the final outcome, best of luck to all involved!!!
See the iBox. This stock symbol was hijacked by crooks and trading was suspended by the DTCC and OSC.
Posted that news earlier, now can you tell me what it means?
Have not been keeping up with this POS.
thx.
Followers
|
130
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
39795
|
Created
|
02/02/07
|
Type
|
Free
|
Moderators |
LATEST NEWS
PMCL Investors Demand Justice ... Or Else !!!
April 28, 2009
Ontario Securities Commission (OSC) Notice
IN THE MATTER OF IRWIN BOOCK, STANTON DEFREITAS, JASON WONG, SAUDIA ALLIE, ALENA DUBINSKY, ALEX KHODJIAINTS, SELECT AMERICAN TRANSFER CO., LEASESMART, INC., ADVANCED GROWING SYSTEMS, INC., INTERNATIONAL ENERGY LTD., NUTRIONE CORPORATION, POCKETOP CORPORATION, ASIA TELECOM LTD., PHARM CONTROL LTD., CAMBRIDGE RESOURCES CORPORATION, COMPUSHARE TRANSFER CORPORATION, FEDERATED PURCHASER, INC., TCC INDUSTRIES, INC., FIRST NATIONAL ENTERTAINMENT CORPORATION, WGI HOLDINGS, INC. and ENERBRITE TECHNOLOGIES GROUP
TORONTO – The Commission issued an Order which provides that the hearing of this matter on the merits shall be held on Monday, October 19, 2009 through to Friday, November 13, 2009, excluding Wednesday, November 11, 2009, commencing each day at 10:00 a.m. at the offices of the Commission on the 17th floor, 20 Queen Street West in Toronto.
OFFICE OF THE SECRETARY
JOHN P. STEVENSON, SECRETARY
URL: http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20090428_boocki.jsp
A copy of the Order dated April 22, 2009 is available at:
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090422_boocki.jsp
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090422_boocki.pdf
For Investor Inquiries:
OSC Contact Centre
416-593-8314
1-877-785-1555 (Toll Free)
For OSC Media Inquiries:
Wendy Dey - Director, Communications & Public Affairs - (416) 593-8120
Laurie Gillett - Manager, Public Affairs - (416) 595-8913
Carolyn Shaw-Rimmington - Assistant Manager, Public Affairs - (416) 593-2361
All OSC releases for PMCL: http://www.osc.gov.on.ca/Enforcement/Proceedings/AlphaListing/ep_p_index.jsp
Stanton DeFreitas - OSC Press Releases: http://www.osc.gov.on.ca/Enforcement/Proceedings/AlphaListing/ep_d_index.jsp (scroll down to "De Freitas")
June 24: OSC Order for Stanton DeFreitas (Trader): http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20080624_defreitas.jsp
June 25: OSC Notice for Stanton DeFreitas (Trader): http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20080625_defreitas.jsp
Who is Stanton DeFreitas ?
S.B.J. DeFreitas is a financial and strategy consultant to various high net worth individuals and business enterprises across the globe with a focus on North America and the OECS. His background in the North American banking, brokerage and insurance sectors, estate, tax and strategic planning, coupled with his concentration on the offshore industry make him a multi-faceted consultant who can contribute to a variety of assignments for any client.
DeFreitas and Associates: http://www.defreitas-consulting.com/practitioner_sbj.htm
February 27, 2009
Securities and Exchange Commission (SEC) Order
SEC Suspends Trading of Imark Technologies, Inc. (n/k/a Pharm Control Ltd.) on Feb 27, 2009
"It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Imark Technologies, Inc. (n/k/a Pharm Control Ltd.) because it has not filed any periodic reports since the period ended March 31, 1998."
http://www.sec.gov/litigation/suspensions.shtml
http://www.sec.gov/litigation/suspensions/2009/34-59466.pdf
http://www.sec.gov/litigation/suspensions/2009/34-59466-o.pdf
Ontario Securities Commission (OSC) Notice
IN THE MATTER OF Irwin Boock, Stanton DeFreitas, Jason Wong, Saudia Allie, Alena Dubinsky, Alex Khodjiaints, Select American Transfer Company, LEASESMART, INC., ADVANCED GROWING SYSTEMS, INC., INTERNATIONAL ENERGY LTD., NUTRIONE CORP., POCKETOP CORP., ASIA TELECOM LTD., PHARM CONTROL LTD., CAMBRIDGE RESOURCES CORP., COMPUSHARE TRANSFER CORP., FEDERATED PURCHASER, INC., TCC INDUSTRIES, INC., FIRST NATIONAL ENTERTAINMENT CORP., WGI HOLDINGS, INC. and ENERBRITE TECHNOLOGIES GROUP
The Commission issued an Order adjourning the hearing until February 17, 2009 at 3:00 p.m. for the purpose of having a pre-hearing conference on that date.
Source: http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20090206_boocki.jsp
January 20, 2009
Ontario Securities Commission (OSC) Order
Temporary Orders in respect of the Corporate Respondents and in respect of Boock and DeFreitas were extended until the conclusion of this proceeding or until further order of the Commission with an exception allowing Boock to trade in his existing RRSP account in securities that are listed on the Toronto Stock Exchange or New York Stock Exchange, provided that Boock provides to Staff copies of the monthly account statements for the RRSP account on a timely basis.
Submissions from counsel for Staff of the Commission, counsel to Boock, DeFreitas, and Enerbrite Technologies, respectively, and from Alena Dubinsky and Alex Kodjiaints on their own behalf, and upon being advised that Jason Wong through his counsel does not object to the order being sought by Staff, with no one appearing for the balance of the Individual and Corporate Respondents.
The hearing is adjourned until February 17, 2009 at 3 p.m. for the purpose of having a pre-hearing conference on that date.
Source: http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090120_boocki.jsp
PDF: http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20090120_boocki.pdf
January 12, 2009
Shareholders Discovered Pharm Control Ltd Web Site is Shut Down: http://www.control24online.com
Analsyis of Pharm Control Ltd Web Sites Using GoDaddy.com: http://investorshub.advfn.com/boards/read_msg.asp?message_id=23093369
Diabetes product, Control 24™, is available at alleged CEO Dr. Lee's web site: http://www.leejaseng.com/diabetes_news/diabetes_safe.htm
Control 24™
FDA Registration No: 2022038
DEA Registration No: RB0177877
FDA Microbiological Evaluation Test Results: http://www.leejaseng.com/diabetes_news/diabetes_micro_evaluation.jpg
FDA Supplement Facts Test Results: http://www.leejaseng.com/diabetes_news/diabetes_supplement_facts.jpg
FDA Acute Oral Toxicity Test Results: http://www.leejaseng.com/diabetes_news/diabetes_toxicity.jpg
CEO Dr. Lee's web site: http://www.leejaseng.com
CEO Dr. Lee's contact info: http://www.leejaseng.com/company/company.htm
Note: Dr. Lee is CEO of Pharm Control Ltd. according to 2007 press releases.
CEO Profile: Dr. Sang Hee Lee
Dr. Lee continues to practice medicine in Canada and has brought with him 3 generations of knowledge and expertise in Oriental Medicine. He is now the mastermind behind the new line of herbal supplements manufactured by S. H. Herb America Inc. Within his first year, his patients began to multiply rapidly as his Natural Dietary Supplements gained popularity. He has now treated tens of thousands of patients internationally.
Dr. Lee's Medical Practice: http://www.leejaseng.com/company/company.htm
Shareholder Conversation with CEO Dr. Lee: http://investorshub.advfn.com/boards/read_msg.asp?message_id=18237523
CEO Dr. Sang Hee Lee's Manufacturing Facilities
S. H. Herb America Inc.
1940 West Olympic Boulevard
Los Angeles, CA 90006-3704
Phone: (213) 383-1010
Canada business record date: 01/30/2007
S. H. Herb America Canada Inc.
Toronto, Ontario M2N 5P2
CANADA
Note: Pharm Control Ltd has not confirmed the association of this web site with the company or Dr. S.H. Lee. iHub members have tried to contact Dr. Lee by email at info@leejaseng.com.
June 24, 2008 - OSC Temporary Trading Halt Order
Upon hearing submissions from counsel for Staff of the Commission and with the consent of NutriOne and the consent of Pharm Control, with no one appearing for David Watson, Nathan Rogers, Amy Giles, John Sparrow, LeaseSmart, Cambridge Resources, Advanced Growing Systems, The Bighub.Com, Universal Seismic, Pocketop, International Energy, Select American and Asia Telecom; The Commission is of the opinion that it is in the public interest to make this order:
IT IS ORDERED THAT: the hearing to extend the Temporary Orders, as modified, is adjourned until September 9, 2008 at 1:00 p.m.; and pursuant to subsection 127(8) of the Act, the Temporary Orders, as modified, are extended until September 10, 2008 or until further order of the Commission.
Pharm Control Ltd - OSC Press Releases: http://www.osc.gov.on.ca/Enforcement/Proceedings/AlphaListing/ep_p_index.jsp (scroll down to "Pharm Control Ltd")
June 24: OSC Order for PMCL: http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20080624_select_american.jsp
June 25: OSC Notice for PMCL: http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20080625_select_american.jsp
Company Mission Statement
Pharm Control Ltd. is devoted to discovering and developing new remedies that will enable patients to live longer, healthier, and more productive lives. Pharm Control's mission is to develop natural and no side effect supplements to support a normal way of life with Diabetes, High Cholesterol and High Blood Pressure.
Herbal Products and Pipeline
1. Diabetes Solution: Control 24™ - Available Now at Online Store - http://www.control24online.com
2. High Cholesterol Solution: SAPO-Q™ - Available Now at Online Store - http://www.control24online.com
3. High Blood Pressure Solution: Developing - See PR on April 27, 2007
4. Dr. Lee's Medical Practice & Herbal Solutions: http://www.leejaseng.com/company/company.htm
Weekly Share Price Analysis
Company Info
Pharm Control Ltd
47 Redwillow Drive
Toronto, Ontario, M3A 2K8
CANADA
Web: http://www.control24online.com
Phone: (416) 710-5136 (Company Office)
Phone: (416) 562-6030 (Company Office)
Phone: (212) 252-4521 (Investor Relations)
Fax: (416) 391-3802
State Of Incorporation: Delaware, USA
Canada Business Number: 861-16-2253
Company Share Structure
Outstanding Shares: 40,832,508 (as of Dec 12, 2006)
Management Owned Shares: 30,000,000 (Estimated)
Anticipated Outstanding Shares After Future 8:5 Forward Split: 65,332,013 (May 11, 2007 PR)
iHub Member Survey: 85 shareholders, 25,652,730 shares - http://investorshub.advfn.com/boards/read_msg.asp?message_id=24265089
Stock Transfer Agent
First American Stock Transfer
706 East Bell Road, Suite 202
Phoenix, AZ 85022-6642
Phone: (602) 485-1346
Fax: (602) 788-0423
POC: Salli A. Marinov
Email: Salli@firstamericanstock.com
Website: http://www.firstamericanstock.com
Business Description
Pharm Control Ltd. is a leading all natural medicine, research and development company devoted to inventing herbal-based remedies that allow patients to live longer, healthier, and more productive lives. Its founders have invested over 10 years of research discovering and developing new and effective, non-synthetic ways to fight and relieve disorders and sickness in the modern world.
Mission Statement
Pharm Control Ltd. is devoted to discovering and developing new remedies that will enable patients to live longer, healthier, and more productive lives. Pharm Control's mission is to develop natural and no side effect supplements to support a normal way of life with Diabetes, High Cholesterol and High Blood Pressure.
Company Officers
Dr. Sang Hee Lee: President, CEO, http://www.leejaseng.com/company/company.htm
Eugene Kron: Vice President, Press Release POC: (212) 252-4521
Yevgen Konaryev: Vice President, Director
Jae Ho Kim: Vice President, Director: http://www.henryfordhealth.org/11486.cfm
Ho Sup Song: Secretary, Treasurer: http://www.keri.org/eng/about/org_supt03.asp
Note: The association of the above 3 web sites with PMCL company officers has not been confirmed to date. Provided for research purposes only.
Company Email:
General Company Info: contact@control24online.com
Product Info: info@control24online.com
CEO Sang Hee Lee: info@leejaseng.com, jasengca@hotmail.com
VP Eugene Kron: pmclinfo@yahoo.com, pharmcontrol@gmail.com
Stock Transfer Agent: Salli@firstamericanstock.com
Company Products and Pipeline
1. Diabetes Solution: Control 24™ - Available Now at Online Store - http://www.control24online.com
2. High Cholesterol Solution: SAPO-Q™ - Available Now at Online Store - http://www.control24online.com
3. High Blood Pressure Solution: Developing - See PR on April 27, 2007
4. Dr. Lee's Medical Practice & Herbal Solutions: http://www.leejaseng.com/company/company.htm
Diabetes Soltuion: Control 24™ is Available Now
Control 24™: Learn more about patient test results, testimonials and an interview with CEO Dr. Lee: http://www.leejaseng.com/diabetes_news/diabetes_news.htm
FDA Testing: Herb/food supplement testing successful at the Bio-Science Research Institute, a FDA registered testing laborartory in Chino, California - http://www.bio-scienceresearch.com
Dr. Lee's Medical Practice: http://www.leejaseng.com/company/company.htm
High Cholesterol Solution: SAPO-Q™ is Available Now
SAPO-Q™: the all natural food supplement, helps to reduce cholesterol levels of adults suffering from high levels of cholesterol. It is 100% natural and side effect free, fully made of Oriental herbs which have several thousands years of tradition and usage.
The Bio-Science Research Institute Inc. in FDA adjudges SAPO-Q to be free from acute oral toxicants. Learn more about this Cholesterol Care Natural Solution now available for purchase at the Online Store:
FDA Testing: Herb/food supplement testing successful at the Bio-Science Research Institute, a FDA registered testing laborartory in Chino, California - http://www.bio-scienceresearch.com
High Blood Pressure Solution: Herbal-Based Product Available Soon
"Pharm Control is proud to announce that the company is intensely researching and developing a new product that is an all-natural medication to reduce blood pressure for high blood pressure sufferers. The Company hopes to bring this product to market shortly both in Europe and North America where the market for such a product is high." (April 18, 2007 PR)
Company Info on the Web
Pink Sheets: http://www.pinksheets.com/pink/quote/quote.jsp?symbol=PMCL
OTCBB: http://www.otcbb.com/asp/quote_module.asp?qm_page=90408&symbol=PMCL
Yahoo: http://finance.yahoo.com/q?s=PMCL.PK
Qwoter: http://www.qwoter.com/profiles/item.php?id=34&dir=1
Announced Stock Listing Changes
Company name: Natural Medicines Inc.
Stock symbol: NATM.PK
CUSIP: 63889A101
European IPO: Natural Medicines AG - New European Distribution Company (Feb 21, 2007 PR)
Shareholder Dividend: "one new share of Natural Medicines AG for every three shares of Pharm Control" (May 16, 2007 PR)
Asian IPO: "The Company is looking into listing the (stock) for trading in overseas markets with an emphasis on South East Asia." (April 27, 2007 PR)
iHub Member Research: http://www.investorshub.com/boards/read_msg.asp?message_id=19279195
iHub Member Comments on Potential PMCL Sales in South Korea: http://investorshub.advfn.com/boards/read_msg.asp?message_id=18196450
WHY ARE DISCOUNT BROKERS BLOCKING BUY ORDERS AND ONLY ALLOWING SELL ORDERS OF PMCL SHARES ?
Temporary Trading Halt Order by OSC and DTC
Source: http://www.osc.gov.on.ca/Enforcement/Proceedings/ENR/enr_20071218_watsond.jsp
Ontario Securities Commission (OSC) Temporary Trading Halt Order (May 22, 2007)
"Select American, acting as the transfer agent to these companies, may have issued false share certificates for trading in securities of these issuers in the over-the-counter securities market via the Pink Sheets."
Source: http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20070522_select-american.jsp
Pharm Control Ltd (PMCL) Responds to OSC Allegations (May 25, 2007)
"The Management of Pharm Control Ltd. would like to notify all shareholders that it vehemently denies any allegations made by the Ontario Securities Commission (OSC) in its Press Release. The Company will have its lawyers vigorously pursue all avenues to clarify these matters on behalf of its shareholders."
Source: http://biz.yahoo.com/iw/070525/0257794.html
Depository Trust Company (DTC) Response to OSC Temporary Order (May 25, 2007)
Source: http://www.dtc.org/impNtc/ope/ope_1641.pdf
Ontario Securities Commission (OSC) Temporary Trading Halt Order (June 25, 2007)
"Trading in any securities by Select American Transfer Co. ("Select American") shall cease. Submissions from counsel representing Pharm Control have consented to the extension of the June 1st Order until September 28, 2007."
http://www.osc.gov.on.ca/Enforcement/Proceedings/RAD/rad_20070625_selectamerican.jsp (June 25, 2007)
NOTE: Fidelity and Bank of America are the only known discount brokers that are allowing people to buy PMCL shares as of Septbember 24, 2007.
OSC Contact Information
Phone: 1-877-785-1555 (Toll Free)
Email: inquiries@osc.gov.on.ca
News Releases: http://www.osc.gov.on.ca/Media/NewsReleases/2007/nr_2007_index.jsp
2007 COMPANY PRESS RELEASES - APPARENTLY ALL COMPLETELY FALSE & MISLEADING STATEMENTS
Market Wire: http://www.marketwire.com/mw/search.do?params=&grpSearch=C&companyid=35770
Yahoo: http://finance.yahoo.com/q?s=PMCL.PK
Qwoter: http://www.qwoter.com/profiles/item.php?id=34&dir=1
May 25, 2007: Pharm Control Responds to OSC Allegations (Market Wire)
The Management of Pharm Control would like to notify all shareholders that it vehemently denies any allegations made by the Ontario Securities Commission (OSC) in its Press Release. The Company will have its lawyers vigorously pursue all avenues to clarify these matters on behalf of its shareholders.
May 16, 2007: Pharm Control Shareholder Update (Market Wire)
The Board of Directors of Pharm Control has decided to dividend out to shareholders one new share of Natural Medicines AG for every three shares of Pharm Control held by shareholders of record on Friday, July 13, 2007. Discussions with European investment bankers have revealed to Company management that the anticipated trading level for the new European entity will be in the area of 0.25 Euros. This dividend will be paid after the 8 new for 5 old dividend payment of Pharm Control at the end of June. Pharm Control's management anticipates the name change and CUSIP number change to become effective any day now and will follow up with another shareholder update along with the name of the new transfer agent once all is completed.
May 11, 2007: Pharm Control Shareholder Update (Market Wire)
The Board of Directors of Pharm Control is proud to announce that they have decided to reward patient shareholders with a forward stock split whereby shareholders of record on June 29, 2007 will receive eight (8) new shares for every five (5) shares they hold. The company intends to proceed with the previously announced stock spin-off of the European distribution company after this dividend is completed. Pharm Control is still in the process of completing its change of transfer agents while awaiting the approval of the new stock symbol by the NASD.
May 4, 2007: Pharm Control Announces Formation of New Marketing and Distribution Unit (M2 PRESSWIRE via COMTEX)
Pharm Control Ltd is pleased to announce that after discussions with European investment bankers, the Company has decided to form a new corporation called Natural Medicines AG, which will serve as the Company's marketing and distribution arm of in Europe.
The Company intends to spin off by way of stock dividend ownership of this new entity to its shareholders. This will be done after the Company makes the necessary arrangements to list this company on a European stock exchange in the coming months.
Further information including dividend dates will be forthcoming.
CONTACT: Eugene Kron, Vice President, Pharm Control Ltd. Tel: +1 212 252 4521 e-mail: pmclinfo@yahoo.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
April 27, 2007: Pharm Control Shareholder Update (Market Wire)
Pharm Control would like to update its shareholders by advising that the Company anticipates the name change to Natural Medications Inc., the new CUSIP and new symbol to be processed by some time in early May 2007. In addition, the Board of Directors increased the Authorized Shares to 1 billion in order to have the flexibility of possible financings in the future but also to pursue acquisitions, particularly manufacturing facilities in Southeast Asia. As part of this potential growth, the Company is looking into listing the Company for trading in overseas markets with an emphasis on South East Asia.
April 18, 2007: Pharm Control Announces New Product Developments (Market Wire)
Pharm Control is proud to announce that the Company is intensely researching and developing a new product that is an all-natural medication to reduce blood pressure for high blood pressure sufferers. The Company hopes to bring this product to market shortly both in Europe and North America were the market for such a product is high. In regard to Shareholder Update dated April 5, 2007, the Company anticipates the name change to Natural Medications Inc. and the new CUSIP number will be completed in the upcoming weeks.
April 5, 2007: Pharm Control Ltd Shareholder Update (M2 PRESSWIRE via COMTEX)
Pharm Control Ltd is announcing its plan to change the Company's name to Natural Medications Inc. The new Corporate name is a better reflection of the Company's mandate of researching and developing non-synthetic medicines.
Management also wishes to advise its shareholders that all existing shares will be exchanged on a one existing share for one new share basis (1 for 1) once the Name Change has been confirmed and the new CUSIP number has been obtained.
It is management's hope that these initiatives taken will combat the recent short selling of the Company's shares.
CONTACT: Eugene Kron, Vice President, Pharm Control Ltd. Tel: +1 212 252 4521 e-mail: pmclinfo@yahoo.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
March 22, 2007: Pharm Control Ltd Victim of Short Selling (M2 PRESSWIRE via COMTEX)
Pharm Control Ltd management is in the process of ordering a current Non Objecting Beneficial Owners list (NOBO list) from ADP Investor Communications. This is in response to the various emailssent and calls made to the Company's offices concerning possible short selling of the Company's stock.
The NOBO list shows a more complete and comprehensive shareholder profile than is typically available on a shareholder list provided by a transfer agent. In addition, management will order Depository Trust Corporation (DTC) reports for further examination. Both lists will be utilized to uncover possible short positions.
The NOBO list will be used to determine the naked short position in Pharm Control's common stock. The NOBO list will be compared to the reports from the DTC which contains data regarding all brokers and amounts of shares being held for investors. These lists will be used to get a total amount of shares owned by all shareholders and any naked short positions. The findings will then be reported to the NASD (National Association of Securities Dealers) to take action against the violators of the naked short regulations.
The company will take all necessary action to protect the value of shareholder investments and the steps now being taken exhibit the Company's response to the various emails send and calls made to our offices by investors.
CONTACT: Eugene Kron, Vice President, Pharm Control Ltd. Tel: +1 212 252 4521 e-mail: pmclinfo@yahoo.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
February 21, 2007: Pharm Control Plans Listing Changes (Qwoter.com)
The management of Pharm Control has announced plans to have the Company’s stock listed on a higher exchange next year in the United States. Concurrent with an enhanced listing in the USA, the Company plans to apply for listings on European and other international exchanges. Management is anticipating revenue for 2007 to exceed US $18,000,000 with 2008 early projections being in excess of US $50,000,000. Profit margins are anticipated to be in excess of 20%. Pharm Control Vice President, Eugene Kron has stated, “listings on higher and overseas exchanges should increase the profile of the company dramatically.”
February 20, 2007: Pharm Control Anticipates Revenue Growth for the first half of 2007 (Qwoter.com)
Pharm Control estimates that European sales should total US $8,400,000.00 in the first 6 months of operations with further increases anticipated as the company expands into other European markets where natural and homeopathic remedies are readily accepted.
January 30, 2007: Pharm Control Announces the Acquisition of Licensing Rights in Europe (Market Wire)
Pharm Control is proud to announce the acquisition of licenses required to sell its products in Poland and Germany, where natural and homeopathic acceptance of natural solutions is well known. The first trial shipments of pills have been shipped to Germany and Poland and the Company expects that its Control 24™ product will be available on the shelves in both countries by the middle of 2007.
iHub Member Comment on Wal-mart: http://investorshub.advfn.com/boards/read_msg.asp?Message_id=18000672&txt2find=european
January 24, 2007: Pharm Control Announces Preliminary Talks With Wal-Mart (Market Wire)
As part of its continuing efforts to broaden product distribution, Pharm Control has made an application and has had preliminary talks with Wal-Mart to become a new supplier. As part of these discussions the company has been given a Supplier Application Number. The company expects talks to continue this year.
January 23, 2007: Pharm Control Now Trading on the OTC (Market Wire)
Pharm Control is pleased to announce that the company now trades on the OTC pink sheets under the symbol PMCL. The company is focused on the development of natural, no side effect supplements to cure diseases such as Diabetes, high blood pressure and high cholesterol related sicknesses, digestive disorders, liver and kidney diseases. The first product in the development pipeline is Control 24™, a natural product that is focused on the Diabetes and pre-Diabetes market.
Disclaimer
This board, the moderator and assistants are not associated with Pharm Control Ltd. or any firms under contract to promote Pharm Control Ltd.
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Please review the Investors Hub Terms of Service (TOS) for the message posting rules. Posting on internet message boards is not anonymous and you can be held liable for spreading false and misleading information about people and companies. Post at your own risk.
TOS Refresher: http://investorshub.advfn.com/boards/complex_terms.asp
For more information regarding investments and Internet fraud, please visit the SEC web site: http://www.sec.gov/sitemap.shtml and http://www.sec.gov/investor/pubs/cyberfraud.htm
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |